Introduction
============

Fine particles---those defined as aerosols with aerodynamic diameter ≤ 2.5 μm (PM~2.5~)---in the atmosphere have been well known for their potential negative impacts on human health that can affect the respiratory, cardiovascular, and cerebrovascular systems. The robust association between ambient PM~2.5~ mass concentration and public health has been demonstrated by epidemiologic studies across the world ([@r27]; [@r17]; [@r26]; [@r8]), but most previous studies focused on a limited range of ambient annual average concentrations, typically from approximately 5 μg/m^3^ to 30 μg/m^3^, in developed countries ([@r10]; [@r27]; [@r26]). Recent studies (e.g., [@r24], [@r25]; [@r5]) enabled the extension of the traditional calculation method for global scale applications by using increments of cigarette smoking as equivalent concentration of PM~2.5~. As one example, the integrated exposure--response model (IEM) reported in the Global Burden of Disease study ([@r5]) was successfully applied in an estimation of health impacts of long-term exposures to PM~2.5~ at the global scale: The result suggests the number of deaths attributable to ambient PM~2.5~ was 3.2 million worldwide in 2010 ([@r20]).

Assessment of the avoided human health impacts associated with air quality improvements is critical for the design and implementation of air pollution control policy. Some studies have estimated air quality changes and health benefits from emission mitigations by using sensitivity analysis with a chemical transport model. For example, [@r13] quantified the health benefits from controls on different locations, sources, and emission types by employing the Community Multiscale Air Quality (CMAQ) response surface model. They further characterized the PM~2.5~ air quality impacts and human health benefits from 17 emission sectors across the contiguous United States by using the Comprehensive Air Quality Model with Extensions (CAMx) source apportionment air quality modeling techniques ([@r12]). [@r18] calculated the sensitivities of global PM~2.5~-related premature mortality (referred to as PM~2.5~-mortality in this article) to emissions by using the adjoint of the GEOS-Chem chemical transport model ([@r18]; [@r15]). [@r19] used the zero-out method in a global atmospheric chemistry model to investigate the link between premature mortality and seven emission source categories for conditions representative of 2010. To date, however, little effort has been devoted toward assessing long-term exposure to PM~2.5~ and health impacts associated with recent historical trends in air pollution. Compared to the sensitivity analysis that relies heavily on the baseline situation (i.e., the nonlinearly responding functions), a historical trend analysis is better constrained, since it is based on actual documented changes. However, a challenge with the approach is the quantification of a reliable historical trend in PM~2.5~ concentrations with adequate spatial resolution.

Anthropogenic emissions of primary aerosol and gaseous precursors of PM~2.5~ have witnessed dramatic changes over the past two decades across the northern hemisphere. During the period 1990--2010, sulfur dioxide (SO~2~) and nitrogen oxides (NO~x~) emissions across the United States decreased by about 66% and 50%, respectively (e.g., [@r37]), while emissions have increased dramatically in many developing regions. These changing emissions have resulted in contrasting trends in the regional aerosol burden across the northern hemisphere. Understanding the historical trend in long-term exposure to PM~2.5~, as well as the health benefits from the air pollution controls in the developed countries and the health risks arising from the deterioration of air quality in developing countries, is crucial for policy design in the future.

This study aims to provide an estimation of historical trends in long-term exposure to PM~2.5~ and its impact on PM~2.5~-mortality during 1990--2010 across the northern hemisphere. We first detail the method used to calculate PM~2.5~-mortality and emission mitigation efficiency (EME). The estimated long-term exposure to PM~2.5~ and mortality and their response to changes in emissions is then quantified. Uncertainties and implications for future trends in air pollution exposure are also discussed.

Methods
=======

Historical Emission and PM~2.5~ Concentration Trend
---------------------------------------------------

Historical emission trends of gaseous pollutants and primary particles used in this study are derived from the combination of the year-specific inventory from the Emissions Database for Global Atmospheric Research (version 4.2; EDGAR) ([@r11]) for the period 1990--2008 and an extrapolation for the years of 2009 and 2010 based on recent estimates of activity change ([@r36]). The SO~2~, NO~x~, volatile organic compounds (VOC), and primary PM emissions in Europe and high-income North America (includes Canada and the United States) ([@r23]) have seen continuous reductions by 5.4/5.4%, 1.5/1.8%, 3.3/3.3%, and 4.8/4.6% per year, respectively, during 1990--2010. In contrast, SO~2~, NO~x~, and VOC emissions in East Asia have increased continuously by 3.2%, 4.2%, and 2.3% per year, respectively. Stricter controls on primary PM emissions have been implemented in China since 2003 ([@r31]), thus its positive (+) 0.3% per year increase rate is much smaller compared to gaseous pollutants. Ammonia (NH~3~) emissions exhibit an increasing trend both in China (+2.6% per year increase) and in the United States (+1.6% per year increase) but exhibit a declining (--) trend in Europe (--1.0% per year) due to stricter controls. Additional details on the emission processing for the model simulations are provided in [@r36].

The 1990--2010 gridded annual average PM~2.5~ concentrations with 108 km × 108 km resolution over the northern hemisphere (see domain coverage presented in [Figure 1](#f1){ref-type="fig"}) are obtained from simulations with a hemispheric version of the Weather Research and Forecast (WRF) model coupled with the CMAQ model developed by the U.S. Environmental Protection Agency (EPA) ([@r34]; [@r29]). CMAQ is a sophisticated modeling system which has multiple capabilities of simulating concentrations of fine particulate and other air pollutants in the atmosphere involving complex pollutant interactions on urban (e.g., [@r38]), regional (e.g., [@r2]) and hemispheric ([@r21], [@r22]) scales. An extensive examination of the model's ability to capture trends in gaseous precursors, PM~2.5~ chemical composition and aerosol burden has been conducted through comparison with multi-decadal trends in observations. First, the ability of WRF-CMAQ in reproducing the historical trend in AOD over the northern hemisphere has been quantitatively evaluated through a comparison of simulated values over the 21-years with six satellite-retrieved AOD products including AVHRR, TOMS, SeaWiFS, MISR, MODIS-Terra and MODIS-Aqua as well as long-term historical records from 11 AERONET sites during the 1990--2010 period ([@r35]). Second, the model performance for simulation of gaseous species and PM~2.5~ composition was future evaluated through comparison with measurements at several ground observation networks mostly over Europe and North America over the past two decades. Results suggested that model simulated ambient PM~2.5~ trends over the past two decades largely agree with those derived from observations ([@r36]).

![The northern hemisphere model simulation domain and the six selected subregions used in the analysis: East Asia, high-income North America, Europe, South Asia, North Africa and the Middle East, eastern and western sub-Saharan Africa. The map used in this figure was created using ArcGIS software by Esri (http://www.esri.com).](EHP298.g001){#f1}

Estimates of Health Impacts Due to Long-Term Exposure to PM~2.5~
----------------------------------------------------------------

The PM~2.5~-mortality estimated in this study includes five causes of premature mortality: ischemic heart disease (IHD), cerebrovascular disease (stroke), chronic obstructive pulmonary disease (COPD), lung cancer (LC) for adults \> 25 years old, and acute respiratory lung infection (ALRI) for children \< 5 years old. The method is based on the algorithm in the Environmental Benefits Mapping and Analysis Program-Community Edition (BenMAP CE) (e.g., [@r30]), released by the U.S. EPA, and the Integrated exposure--response model from global burden of disease (GBD) ([@r20]; [@r5]).

The concentration--response function (Equation 1) is summarized as below:

*Mortality~PM~* ~2.5~ = Σ*~i~* ~=~ *~IHD,\ stroke,\ COPD,\ LC,\ ALRI~ incidence* ~0,~ *~i~* × *PAF~i~* × *Population* \[1\]

in which, *incidence* ~0~ *~,i~* is the baseline incidence rate of the cause-specific premature mortality of *i*. The value of *incidence* ~0~ *~,i~* is based on [@r23]. *PAF~i~* is population attributable fraction (PAF) of the cause-specific premature mortality of *i*. The value of *PAF* is defined by Equation 2:

*PAF~i~* = (*RR~i~ -- 1*)/*RR~i~* \[2\]

where *RR~i~* is the relative risk for the cause-specific premature mortality of *i* (Equation 3):
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\[3\]

where, *C* is the ambient PM~2.5~ concentration, and *C* ~0~ is the threshold value of PM~2.5~ concentration below which there is no additional risk assumed in this study. 〈, γ, and δ are parameters that determine the overall shape of the concentration--response relationship ([@r5]). In the calculations presented here, the estimates of relative risks (i.e., *RR~i~* in Equation 2) were obtained from the look-up table developed by [@r3], which reports RR for PM~2.5~ concentrations in the 0-410 μg/m^3^ range in 0.1 μg/m^3^ steps.

The gridded population data are interpolated from the 1990, 1995, 2000, 2005, and 2010 Gridded Population of the World (version 3; GPW) ([@r9]). The population age structures were obtained from [@r1]. The original population data on a 0.25° × 0.25° grid was apportioned to individual grid pixels matching the model grid (108 km × 108 km). The population-weighted average PM~2.5~ is estimated from the annual average PM~2.5~ concentrations weighted by the population. To quantify the correlations between population and PM~2.5~, we defined the ratio of population-weighted average PM~2.5~ to regional average PM~2.5~ as the population scale factor (PSF). Thus, a large PSF (\> 1) indicates a positive correlation between population and PM~2.5~, while a small PSF (\< 1) indicates a negative correlation between population and PM~2.5~.

Calculation of EME
------------------

EME, an index to represent the health benefits from unit emission reduction in different source categories, has previously been estimated using sensitivity analysis methods ([@r13], [@r12]; [@r18]; [@r19]). In this study, we utilized the changes in air pollution-attributed health effects and emissions over the past two decades to estimate the EME. The simulation of year 1990 is defined as the baseline scenario. Each of the other years simulated from 1991 to 2010 then represents 20 scenarios with different emission and meteorological conditions relative to 1990. A principle similar to that in source apportionment methods was adopted; changes in concentrations of inorganic aerosols (i.e., sulfate, nitrate, and ammonium) are attributed to changes in emissions of their corresponding precursors (i.e., SO~2~, NO~x~, and NH~3~, respectively), though it is important to note that this is only a first-order approximation due to the nonlinear coupling of the atmospheric SO~x~--NO~x~--NH~x~ system. Changes in concentrations of other inorganic particles (excluding sulfate, nitrate, and ammonium) as well as primary organic aerosols are attributed to the change in their emissions (noted as primary PM). Since PM~2.5~ mass is still considered the most robust indicator of mortality impacts in epidemiologic cohort studies of long-term exposure ([@r7]), the assumption here is that the health effects of exposure to PM~2.5~ are independent of source and composition ([@r18]). Thus, the impact of various pollutants on mortality are estimated to be proportional to their contribution to PM mass. However, considering the non-linearity of the risk-curve, these estimates could be considered to be on the higher side for cases where one component changes but the others are constant. The year specific EME for each year in the period 1991--2010 relative to the base year of 1990, for an aerosol species, *p* (where *p* = SO~2~, NO~x~, NO~3~, or primary PM), is then estimated as follow:
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\[4\]

where *y* = 1990...2010 and PM*~p~* represents SO~4~ ^2--^, NO~3~ ^--^, NH~4~ ^+^, or other inorganic particles and primary organic aerosols, and
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\[5\]

where *y*´ = 1991...2010.

To limit the influence of year-to-year variations in meteorological condition, the 21-year average EME for a particular species was estimated from a linear regression of the changes in PM~2.5~-mortality and emissions of 1991--2010 relative to 1990.

Results
=======

Population-Weighted PM~2.5~ and Population Scaled Factor (PSF)
--------------------------------------------------------------

We focus our analysis on six selected regions within the northern hemisphere simulation domain displayed in [Figure 1](#f1){ref-type="fig"}, including two highly populated and polluted regions (East Asia and South Asia), two well-developed regions (Europe and high-income North America), and two regions within or downwind of deserts (North Africa and the Middle East, eastern and western sub-Saharan Africa). The distribution of surface PM~2.5~ concentrations across grid cells grouped by population in six regions is presented in [Figure 2](#f2){ref-type="fig"}. In East Asia and South Asia, most of the population is concentrated in the areas with high annual average PM~2.5~ concentrations exceeding 10 μg/m^3^, which is the World Health Organization's air quality guideline for PM~2.5~ ([@r33]). Additionally, compared to 1990, in 2010 a larger population (i.e., area under the curve) was exposed to higher PM~2.5~ levels, suggesting that greater health risks due to PM~2.5~ likely occurred in recent years in these two regions. In the well-developed regions (i.e., Europe and high-income North America), population exposure to high PM~2.5~ levels (\> 10 μg/m^3^) was much greater in 1990 than in 2010, indicating the health benefits from air quality improvement resulting from emission reductions. In the two desert regions (i.e., North Africa and the Middle East, eastern and western sub-Saharan Africa), the range of PM~2.5~ levels to which populations are exposed were similar in 1990 and 2010, but due to population growth, a much greater number of people were exposed to PM~2.5~ in 2010 than in 1990. Also, the increased populations were mainly concentrated in the areas with high PM~2.5~ levels (\> 10 μg/m^3^), suggesting greater health risks due to PM~2.5~.

![Changing population exposure to ambient PM~2.5~ levels across the six subregions used in the analysis: (*a*) East Asia, (*b*) South Asia, (*c*) high-income North America, (*d*) Europe, (*e*) North Africa and Middle East, and (*f*) eastern and western sub-Saharan Africa, of the northern hemisphere (shown in Figure 1), for the years 1990 (blue dash line) and 2010 (red solid line): Note: Model estimated surface PM~2.5~ concentration across grid cells in a region are grouped by population distributions during 1990--2010. d\[Population\]/d\[log(PM~2.5~)\] represents the population per unit PM~2.5~ section in log scale. The area below a curve represents the total population for that region for that year.](EHP298.g002){#f2}

To further investigate the correlation between PM~2.5~ and population in six typical regions, [Figure 3](#f3){ref-type="fig"} presents comparisons of the historical trend of population-weighted and regional average PM~2.5~ concentrations from 1990 to 2010. Not surprisingly, contrasting trends in PM~2.5~ concentrations were found between developing and developed regions. These trends are comparable with trends in exposure estimates recently suggested in [@r28]. Developing regions of East Asia and South Asia exhibit continually increasing trends in regional average PM~2.5~ concentrations of +0.66 and +0.43 μg/m^3^ per year, respectively, while developed regions, including Europe and high-income North America, have experienced decreasing trends in regional average PM~2.5~ concentrations of --0.37 and --0.14 μg/m^3^ per year, respectively. The population-weighted PM~2.5~ in East Asia and South Asia increased from 24.6 and 15.6 μg/m^3^ in 1990 to 36.1 and 23.0 μg/m^3^ in 2010, while the population-weighted PM~2.5~ in Europe and high-income North America decreased from 16.6 and 14.5 μg/m^3^ in 1990 to 9.6 and 9.1 μg/m^3^ in 2010.

![Comparison of long-term trends (1990--2010) of population-weighted and regional average PM~2.5~ concentrations for the six regions: (*a*) East Asia, (*b*) South Asia, (*c*) high-income North America, (*d*) Europe, (*e*) North Africa and the Middle East, (*f*) eastern and western sub-Saharan Africa, and (*g*) the population scale factor (PSF). Units for both the population-weighted and regional average PM~2.5~ concentrations are shown in μg/m^3^. The population scale factor is the ratio of the population-weighted average PM~2.5~ to the regional average PM~2.5~.](EHP298.g003){#f3}

Additionally, for all regions except North Africa and the Middle East, the population-weighted PM~2.5~ concentrations are always higher than the regional averages. This can be explained by the positive correlation in spatial distributions between population and PM~2.5~ concentrations. In regions where ambient PM~2.5~ is mainly caused by anthropogenic sources, populated areas are usually also polluted, leading to a positive correlation between population and PM~2.5~. However, in regions where natural sources (wind-blown dust) are dominant (e.g., North Africa and the Middle East), since dust areas are not amenable for living, a negative spatial correlation between population and PM~2.5~ concentrations is expected, resulting in lower population-weighted PM~2.5~ compared to the regional averages.

The PSF value can be used to measure the extent of correlation between population and PM~2.5~. Large PSF (\> 1) indicate a positive correlation between population and PM~2.5~. [Figure 3g](#f3){ref-type="fig"} summarizes the PSF trends in the six regions. Large 21-year average PSF (around 2.0) are found in East Asia, Europe and high-income North America. Small PSF are found in North Africa and the Middle East (around 0.79), indicating a negative correlation between the population and PM~2.5~ concentration. Additionally, contrasting PSF trends during 1990--2010 are evident in the six regions. The PSF trends are statistically significant at the 95% confidence level (*p* = 0.05) in all regions except East Asia and eastern and western sub-Saharan Africa. In East Asia and South Asia, the simultaneous growth of population and PM~2.5~ concentrations during the past two decades has led to an increasing trend in PSF from 1.99 and 1.22, respectively, in 1990 to 2.11 and 1.27, respectively, in 2010, suggesting more serious health impacts from exposure to air pollution. Conversely, Europe and high-income North America exhibit decreasing trends in PSF, suggesting increasing health benefits from air pollution controls.

Estimated PM~2.5~-Mortality
---------------------------

The estimated annual average PM~2.5~-mortality for 1990 and 2010 and its change from 1990 to 2010 in the six regions are summarized in [Table 1](#t1){ref-type="table"}. Among the six regions, estimated PM~2.5~-mortality in 2010 was highest in two populated regions with poor air quality, (i.e., East and South Asia), where the PM~2.5~-mortality increased by 21% and 85%, respectively, from 866,000 and 578,000 in 1990, to 1,048,000 and 1,068,000 in 2010. North Africa and the Middle East and eastern and western sub-Saharan Africa also experienced a substantial growth of mortality risk due to PM~2.5~ over the past two decades, with increases in PM~2.5~-mortality of 38% and 53%, respectively. However, in developed regions, including high-income North America and Europe, the PM~2.5~-mortality decreased by 58% and 67%, respectively, in 2010 compared to 1990. The estimates of PM~2.5~-mortality in this study are comparable in magnitude with results in a previous study ([@r20]) as shown in [Table 1](#t1){ref-type="table"}. The differences in estimates compared to [@r20] arise primarily due to differences in the spatial resolution employed in this analysis, since the non-linearity of the risk function enlarges the uncertainties of PM~2.5~-mortality estimates related to the exposure allocation.

###### 

Estimated PM~2.5~-mortality due to long-term exposure to PM~2.5~ in 1990 and 2010 (in thousands).

  Year                                                                                           Case                     East Asia   South Asia   High-income North America   Europe   North Africa and the Middle East   Eastern and western sub-Saharan Africa
  ---------------------------------------------------------------------------------------------- ------------------------ ----------- ------------ --------------------------- -------- ---------------------------------- ----------------------------------------
  1990                                                                                           Lim et al. (2012)^*a*^   947         538          163                         729      136                                97
  This study^*b*^                                                                                866                      578         122          418                         124      96                                 
  2010                                                                                           Lim et al. (2012)        1,271       771          110                         420      176                                105
  This study                                                                                     1,048                    1,068       51           137                         171      147                                
  Incr = (Y~2010~/Y~1990~ -- 1)                                                                  Lim et al. (2012)        34%         43%          --33%                       --42%    29%                                8%
  This study                                                                                     21%                      85%         --58%        --67%                       38%      53%                                
  ^***a***^Data obtained from IHME (2015). ^***b***^Estimated PM~2.5~-mortality in this study.                                                                                                                             

The PM~2.5~-mortality is estimated from the product of three factors (see Equation 1): population, PAF (which depends on PM~2.5~ concentrations), and baseline incidence rate of the cause-specific mortality (influenced by living conditions, access to medical care). Thus, the trend in PM~2.5~-mortality can be driven by changes in these three factors. To estimate the relative contributions of these three factors to changes in PM~2.5~-mortality, we designed three control scenarios. Impacts due to the change of PAF were estimated from the difference between the base case and a control case in which population and baseline incidence rate of the cause-specific mortality were the same as the base case, but the 2010 PM~2.5~ concentration was set to the 1990 PM~2.5~ concentration.

Similarly, impacts due to change in population (or due to change of baseline incidence rate of the cause-specific mortality) were estimated from the difference between the base case and the control case in which the population (or baseline incidence rate of the cause-specific mortality) in 2010 was set to that of 1990, but the other two factors were kept the same as in the base case.

[Figure 4](#f4){ref-type="fig"} displays the changes in PM~2.5~-mortality due to three factors in six regions. In East Asia and South Asia, the increase in PM~2.5~ concentration caused an increase in mortalities of 247,000 and 219,000, respectively. The benefits for the PM~2.5~-mortality reduction from the improvement in living conditions and the quality of medical care has been offset by the increased health risk from the deterioration of air quality. Compared to East Asia, the total increase of PM~2.5~-mortality in South Asia is larger because of a larger contribution from population growth and a smaller reduction from the improvement of living conditions and the quality of medical care. In Europe and high-income North America, the decrease in PM~2.5~ concentrations is the major reason for the reduction in PM~2.5~-mortality, overwhelming the impact from the other two factors. In the two desert areas (i.e., North Africa and the Middle East and eastern and western sub-Saharan Africa), changes in PM~2.5~-mortality are dominated by population growth. A small fraction of the growth of PM~2.5~-mortality during 1990--2010 was caused by the deterioration in local air quality.

![Relative contributions of the baseline incidence rate, changes in population, and changes in PM~2.5~ concentrations to the estimated PM~2.5~-mortality changes during 1990--2010 in the different regions across the northern hemisphere. Note: Positive numbers indicate an increase in estimated mortality due to exposure to ambient PM~2.5~, while negative numbers represent a reduction.](EHP298.g004){#f4}

Response of PM~2.5~-Mortality to Changes in Local Emissions
-----------------------------------------------------------

Analysis of changes in PM~2.5~-mortality due to emission variations can be used to estimate the relative contributions of SO~2~, NO~x~, NH~3~, and primary PM emissions to mortalities. [Figure 5](#f5){ref-type="fig"} displays the relative change in PM~2.5~-mortality associated with the emission variation of these four pollutants during 1991--2010 relative to 1990. The relative contribution of emissions to PM~2.5~-mortality varied substantially in the three regions where anthropogenic emissions are the dominant sources for PM~2.5~. In East Asia, about 89% of the increase in PM~2.5~-mortality over the past two decades was associated with the increase of SO~2~, NO~x~, and NH~3~ emissions, which have not been as well controlled as primary PM emission, suggesting that the health risk arising in East Asia is mostly due to the increase in secondary inorganic aerosols. The importance of secondary inorganic sources in contributing to PM~2.5~-mortality in East Asia was also noted by [@r18]. In high-income North America, the reduction in PM~2.5~-mortality was mainly from the primary PM and SO~2~ controls, which reduced PM~2.5~-mortality by 20,000 and 19,000, respectively, from 1990 to 2010. However, such health benefits from primary PM and SO~2~ controls are partially (about 11% of the reduction in PM~2.5~-mortality was from primary PM and SO~2~ controls during 1990--2010) counteracted by the increased health risk from the growth of ammonia emissions that resulted in an increase of aerosol nitrate and ammonium concentrations. Since the sensitivity shown in [Figure 5](#f5){ref-type="fig"} is only a first-order approximation, the small negative NH~3~ sensitivity noted in the late 2000s is associated with the substantial reduction of NO~x~ emissions that led to the reduction of particulate ammonium. In Europe, simultaneous controls of all pollutants maximized the health benefit from the emission reductions. The PM~2.5~-mortality was reduced by 87,000, 91,000, 60,000 and 51,000 from 1990 to 2010 due to the emission mitigation of primary PM, SO~2~, NO~x~ and NH~3~, respectively.

![Estimated relative changes in PM~2.5~-mortality associated with changes in SO~2~, NO~x~, NH~3~,and primary PM emissions during 1991--2010 relative to the 1990 values.](EHP298.g005){#f5}

The EME is a useful indicator to quantify the emission mitigation efficiency in reducing the health risk. [Figure 6](#f6){ref-type="fig"} presents the relationship between the change in PM~2.5~ mortalities (ΔPM~2.5~-mortality) and emissions (ΔEmission) for four pollutants in three regions during 1991--2010 relative to 1990. The EME is estimated from the linear regression of ΔPM~2.5~-mortality/ΔEmission (i.e., the slope of the scatter plots in [Figure 6](#f6){ref-type="fig"}). In East Asia, highly linear correlations between ΔPM~2.5~-mortality and ΔEmission are noted for SO~2~ and NH~3~, and the EMEs are 9.8 and 10.8 per k-ton emissions of SO~2~ and NH~3~, respectively. NO~x~ has the highest EME (i.e., 17.9 per k-ton) among all pollutants. This is because the simultaneous increase of NH~3~ emissions facilitates the formation of aerosol nitrate thus enlarging the PM~2.5~-mortality sensitivity to NO~x~ emissions. Compared to other pollutants, the relationship between primary PM emission controls and PM~2.5~-mortality response during 1991--2010 displays no clear trend, indicating that the variation of primary PM emissions does not dominate this relationship in East Asia. As illustrated in [Figure 6a](#f6){ref-type="fig"}, the changes in the magnitude of primary PM emissions in East Asia is much smaller than those of NO~x~, SO~2~, and NH~3~. Further, inter-annual variability in the meteorology may contribute to the variability in the estimated contribution to PM~2.5~ (and its associated mortality). Additionally, uncertainties in estimates of primary PM emissions from household combustion in East Asia could also contribute to the noted weaker relationship. However, a clear positive correlation between the PM~2.5~-mortality response and primary PM emissions was found in high-income North America, where primary PM has the highest EME (12.7 per k-ton), followed by SO~2~, with an EME of 2.3 per k-ton. Due to the increase of NH~3~ emissions over the past two decades, NO~x~ emission reductions show small or even negative PM~2.5~-related health benefits. This is because when HNO~3~ concentrations decline in response to NO~x~ emissions, the growth in NH~3~ facilitates higher partitioning of nitrate to the aerosol phase in NH~3~-limited conditions. These results are consistent with those of [@r12] who reported that directly emitted PM~2.5~ had the highest economic value (estimated from mortalities by applying an estimate of the value of statistical life) for a 1 ton emission reduction, while NO~x~ had the lowest value, and the value for SO~2~ was in between these two. In Europe, all pollutants showed highly linear correlations with the PM~2.5~-mortality responses. The EMEs for primary PM, SO~2~, NO~x~, and NH~3~ were estimated as 28.3, 6.7, 23.7, and 14.8 per k-ton, respectively. The mitigation of primary PM was most effective for the health benefits, followed by the reduction of NO~x~ emissions which became more effective when the NH~3~ emissions were simultaneously controlled. In contrast, in high-income North America where NO~x~ emissions have declined, but NH~3~ emissions have increased, the PM~2.5~-mortality did not show a decline relative to NO~x~ emissions.

![Relationship between changes in PM~2.5~-mortality and changes in emissions in three regions: (*a*) East Asia, (*b*) high-income North America, and (*c*) Europe. Each data point represents the change for each year during 1991--2010 relative to 1990. The slope of the linear regression between the variables represents the emission mitigation efficiency \[i.e., emission mitigation efficiency (EME)\].](EHP298.g006){#f6}

Discussion and Conclusion
=========================

Historical trends in long-term exposure to PM~2.5~ and its impacts on premature mortality were investigated for the period of 1990--2010 across the northern hemisphere. The investigation conducted in this study was based on continuous time series of spatially resolved concentration and population data sets. Contrasting trends in PM~2.5~-mortality over the past two decades are found in developed versus developing regions. Decreasing trends in PM~2.5~-mortality are noted in Europe and high-income North America, and these reductions are mainly associated with the decrease in PM~2.5~ concentrations as well as the improvement in living conditions and the quality of medical care. In contrast, in East and South Asia, the increased health risk from the deterioration of air quality in combination with increasing population offsets the benefits from the improvement in living conditions and the quality of medical care, resulting in an increasing trend in PM~2.5~-mortality over the past two decades.

Strong positive correlations between the spatial distributions of air pollution and population are found in regions where anthropogenic emission sources are dominant. More serious health impacts from air pollution can thus be expected in regions of East Asia where both population and emissions have shown increasing trends (as in the past two decades). On the other hand, additional health benefits from air pollution controls occur when the positive correlation weakens, as witnessed in Europe and high-income North America over past two decades. To maximize the health benefits, one way to weaken such positive correlation could be by encouraging low-density residential developments, or by reducing pollution in high population regions. Such approaches could to be considered in future urban development strategies.

Mitigation of primary PM emissions appears to be the most efficient way for reducing health impacts of exposure to ambient PM~2.5~. Primary PM from combustion of household fuels could be an important contributor to PM~2.5~-mortality in East Asia. The response of PM~2.5~ concentration to NO~x~ emissions varies significantly under different NH~3~ levels (i.e., NH~3~-rich or -poor conditions) (e.g., [@r32]). Thus, the assessment of NO~x~ emission mitigation efficiency in reducing the health risk largely depends on associated measures for NH~3~ emissions. NO~x~ becomes more efficient in reducing PM~2.5~-related health risk with simultaneous control of NH~3~, as illustrated by trends in Europe. However, in conditions of declining NO~x~ but increasing NH~3~ emissions, such as in high-income North America, negligible changes in associated PM~2.5~-mortalities to these species is noted. Thus, simultaneous control of NH~3~ is necessary to maximize the health benefit from NO~x~ emission mitigation.

An assessment of VOC emission controls was not considered in this study due to the likelihood that secondary organic aerosols (SOA) were underestimated in the underlying WRF-CMAQ simulations and also because anthropogenic/biogenic splits are highly uncertain. For example, previous studies suggest that the model may underestimate the SOA formation by a factor of 2--6 ([@r6]; [@r14]; [@r4]). Nevertheless, the importance of VOC mitigation for health benefit should be explored in the future as improvements in the model's ability to simulate SOA are implemented.
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